CD19 and B-cell chronic lymphocytic leukemia: After the 7 days allowed for scaffold engraftment, purified peripheral blood CLL cells (26–300 × 106; >98% CD5+CD19+ cells) were transplanted i.p. and s.c. at the site of the scaffold.